Pneumonia

Feature Article

Intravenous-to-Oral Antibiotics Transition in Healthcare-Associated Pneumonia Safe

Intravenous-to-Oral Antibiotics Transition in Healthcare-Associated Pneumonia Safe

De-escalating antibiotic regimens from intravenous to oral is safe in clinically stable patients with healthcare-associated pneumonia.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Case Synopsis: Late, Recurrent Pneumonia From Endobronchial Sutures

Case Synopsis: Late, Recurrent Pneumonia From Endobronchial Sutures

Endobronchial suture should be considered in patients with recurrent pneumonia that is unresponsive to medical therapy.

Efficacy of Pneumococcal Vaccines for Preventing Pneumonia in COPD

Efficacy of Pneumococcal Vaccines for Preventing Pneumonia in COPD

A Cochrane review found that polyvalent pneumococcal vaccines offered significant protection against CAP in patients with COPD but did not lower the risk of confirmed pneumococcal pneumonia.

Community-Acquired Pneumonia: Statin Potency and Hospitalization Risk

Community-Acquired Pneumonia: Statin Potency and Hospitalization Risk

Contrary to previous studies, this study found an increased hospitalization risk for community-acquired pneumonia with higher-potency vs lower-potency statins.

Antimicrobial Options Assessed for Community-Acquired Pneumonia

Antimicrobial Options Assessed for Community-Acquired Pneumonia

More effective antimicrobial treatments are needed to reduce adverse events burden for patients with community-acquired pneumonia (CAP).

Lung Ultrasonography is Fast and Accurate for Diagnosing Pneumonia

Lung Ultrasonography is Fast and Accurate for Diagnosing Pneumonia

Lung ultrasonography is a rapid, effective alternative to CT scans and chest radiographs for diagnosing pneumonia in the ED and ICU.

Antibiotic Stewardship to Address Overtreatment in Community-Acquired Pneumonia

Antibiotic Stewardship to Address Overtreatment in Community-Acquired Pneumonia

Identifying overtreatment in community-acquired pneumonia opens a path for antibiotic stewardship.

Fewer Pediatric Empyema Hospitalizations Seen With Pneumococcal Vaccine

Fewer Pediatric Empyema Hospitalizations Seen With Pneumococcal Vaccine

Annualized rates of hospitalization for parapneumonic empyema fell after introduction of the 13-valent pneumococcal conjugate vaccine.

Antidementia Drugs May Increase Risk of Pneumonia

Antidementia Drugs May Increase Risk of Pneumonia

Researchers investigated the effect that antidementia drugs have on patients' risk of developing pneumonia.

FDA Grants Fast Track Designation to Drug in Preventing S aureus Pneumonia

FDA Grants Fast Track Designation to Drug in Preventing S aureus Pneumonia

FDA has granted Fast Track designation to ASN100, a novel combination of two fully human monoclonal antibodies to potentially prevent S aureus pneumonia.

Study to Evaluate Shorter Course Antibiotics Use in Children

Study to Evaluate Shorter Course Antibiotics Use in Children

An NIAID sponsored clinical trial will assess effectiveness of a 5-day course of antibiotics in treating community-acquired pneumonia in children.

Sign Up for Free e-newsletters